Shanghai Rochi Pharmaceutical Co.,Ltd. manufactures an unusually broad range of active pharmaceutical ingredients and their synthetic intermediates spanning oncology, cardiology, CNS, diabetes and antiviral therapeutic areas. Its catalog includes elagolix, vonoprazan, dolutegravir sodium, remdesivir, roxadustat, encorafenib, binimetinib, ticagrelor, vorapaxar sulfate, lurasidone hydrochloride, vilazodone hydrochloride, enzalutamide, venetoclax, acalabrutinib, alectinib, brigatinib, afatinib dimaleate, sorafenib tosylate, nilotinib hydrochloride monohydrate, prasugrel hydrochloride, camptothecin and its derivatives (including irinotecan hydrochloride trihydrate), erlotinib hydrochloride, trametinib, empagliflozin, saxagliptin and linagliptin, among many others. Categorized across intermediates/fine chemicals, active pharmaceutical ingredients, amino acids and derivatives, bio products and specialized reagents, the company sells across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.
No comments available.
Leave your rating & comment